计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| S646150-1mg |
1mg |
期货 ![]() |
| |
| S646150-5mg |
5mg |
期货 ![]() |
| |
| S646150-10mg |
10mg |
期货 ![]() |
| |
| S646150-50mg |
50mg |
期货 ![]() |
| |
| S646150-100mg |
100mg |
期货 ![]() |
|
| 别名 | STING 激动剂-4 |
|---|---|
| 规格或纯度 | ≥98% |
| 英文名称 | STING agonist-4 |
| 生化机理 | STING 激动剂-4 是一种干扰素基因(STING)受体激动剂,其表观抑制常数(IC 50)为 20 nM。STING 激动剂-4 是一种基于两种对称性相关氨基苯并咪唑(ABZI)的化合物,可制成连接的 ABZIs(diABZIs),具有以下特点 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
STING agonist-4 is an stimulator of Interferon Genes (STING) receptor agonist with an apparent inhibitory constant ( IC 50 ) of 20 nM. STING agonist-4 is a two symmetry-related amidobenzimidazole ( ABZI )-based compound to create linked ABZIs (diABZIs) with enhanced binding to STING and cellular function In Vitro STING agonist-4 (Compound 2) (0.3-30 μM; 2 hours) causes phosphorylation of IRF3 and STING that is inhibited by the TBK1 inhibitor BX795 and induces dose-dependent secretion of IFN-β with an EC 50 of 3.1 μM. STING agonist-4 (Compound 2) (0.001 nM-1 μM) inhibits binding of full-length STING to the solid support with an apparent dissociation constant (K d ) of approximately 1.6 nM. STING agonist-4 (Compound 2) (0-100 μM) is 18-fold more potent than cGAMP (an endogenous STING ligand), with an EC 50 of 53.9 μM. STING agonist-4 (Compound 2) (3 μM; 4 hours) promotes production of interferon γ-induced protein 10 (IP-10), IL-6 and TNF-α by a mechanism that is dependent on STING-mediated activation of TBK1. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: Human peripheral blood mononuclear cells (PBMCs) Concentration: 0.3 μM, 1 μM, 3 μM, 10 μM and 30 μM Incubation Time: 2 hours Result: Caused phosphorylation of IRF3 and STING and induced secretion of IFN-β. Form:Solid IC50& Target:IC50: 20 nM (STING agonist-4) |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 未知 |
|---|---|
| IUPAC Name | 1-[4-[5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]butyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazole-5-carboxamide |
| INCHI | InChI=1S/C34H38N12O4/c1-5-45-27(15-19(3)41-45)31(49)39-33-37-23-17-21(29(35)47)9-11-25(23)43(33)13-7-8-14-44-26-12-10-22(30(36)48)18-24(26)38-34(44)40-32(50)28-16-20(4)42-46(28)6-2/h9-12,15-18H,5-8,13-14H2,1-4H3,(H2,35,47)(H2,36,48)(H,37,39,49)(H,38,40,50) |
| InChi Key | ICZSAXDKFXTSGL-UHFFFAOYSA-N |
| Canonical SMILES | CCN1C(=CC(=N1)C)C(=O)NC2=NC3=C(N2CCCCN4C5=C(C=C(C=C5)C(=O)N)N=C4NC(=O)C6=CC(=NN6CC)C)C=CC(=C3)C(=O)N |
| Isomeric SMILES | CCN1C(=CC(=N1)C)C(=O)NC2=NC3=C(N2CCCCN4C5=C(C=C(C=C5)C(=O)N)N=C4NC(=O)C6=CC(=NN6CC)C)C=CC(=C3)C(=O)N |
| PubChem CID | 132000066 |
| 分子量 | 678.74 |
| 溶解性 | DMSO : 10 mg/mL (14.73 mM; Need ultrasonic) H2O : <0.1 mg/mL (insoluble) |
|---|---|
| 分子量 | 678.700 g/mol |
| XLogP3 | 2.000 |
| 氢键供体数Hydrogen Bond Donor Count | 4 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 13 |
| 精确质量Exact Mass | 678.314 Da |
| 单同位素质量Monoisotopic Mass | 678.314 Da |
| 拓扑极表面积Topological Polar Surface Area | 216.000 Ų |
| 重原子数Heavy Atom Count | 50 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 1150.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |